Given that the process of AD includes many biochemical changes, such as phosphorylation of tau, oxidative stress, and membrane lipid dysregulation (Toledo et al., 2017), the application of metabolomics may offer a promising perspective in AD diagnosis and functional pathway elucidation. The gene discussed is MAPT; the disease is Alzheimer disease.